CMAJ • October 10, 2006; 175 (8). doi:10.1503/cmaj.1060049.
© 2006 CMA Media Inc. or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, S.
Related Collections
Right arrow Screening tests
Right arrow Other immunology

Letters

Clinical utility of the Coombs test

Sujoy Khan

Specialist Registrar Immunology, PathLinks Immunology, Scunthorpe General Hospital, Scunthorpe, North Lincolnshire, UK

The article by J. Manuel Zarandona and Mark Yazer on the clinical utility of the Coombs test1 prompts consideration of the pitfalls of a negative test result. Specifically, further evaluation will be required if a patient with clinically significant hemolysis has a negative result on Coombs testing.

A negative result on the direct antiglobulin test (DAT) may occur if there are low-affinity antibodies coating the erythrocyte surface that are removed in the washing process or by prior use of corticosteroid therapy. IgG antibodies and C3d complement are detected by the DAT; however, IgM and particularly IgA antibodies may not be detected by the polyclonal antihuman-globulin serum. Therefore, DAT using anti-IgA or anti-IgM antibodies may be required if the results of DAT with anti-IgG antibodies do not correlate with the clinical manifestations. Patients whose erythrocytes are coated with multiple immunoglobulins will have severe hemolysis and may need intensive therapy with immunosuppressive agents2 or even splenectomy.3

At a major immunohematology referral centre in the United Kingdom, 124 of 5235 patients had warm-reactive elutable IgA antibodies and of these, 6 had only IgA autoantibodies coating erythrocytes.4 It is known that IgA complexes can activate the alternative pathway, causing complement activation. Therefore, measurement of complement components C3 and C4 could prove useful in some situations. Splenic sequestration of IgA-sensitized erythrocytes may occur, and in-vitro analysis has shown that monocytes are involved in hemolysis of the sensitized erythrocytes.5 Naturally occurring antibodies of the IgM isotype, which bind complement and autoantibodies of this class, occur in conjunction with anti-IgG and or anti-IgA immunoglobulins. In-vivo autoagglutination of IgM antibodies can lead to multiorgan failure and is usually associated with a high mortality rate.6 Sokol and colleagues7 described 2 patients with only IgM autoantibodies who had chronic hemolysis, one of whom required splenectomy.

It is important that clinicians be aware of the limitations of biological tests and investigate further when a patient with severe hemolysis and organ involvement has a negative Coombs test result.

REFERENCES

  1. Zarandona JM, Yazer MH. The role of the Coombs test in evaluating hemolysis in adults. CMAJ 2006;174(3):305-7.[Free Full Text]
  2. Sokol RJ, Booker DJ, Stamps R, et al. Autoimmune hemolytic anemia due to IgA class autoantibodies. Immunohematology 1996;12(1):14-9.
  3. Bardill B, Mengis C, Tschopp M, et al. Severe IgA-mediated auto-immune haemolytic anaemia in a 48-yr-old woman. Eur J Haematol 2003;70(1):60-3.[CrossRef][Medline]
  4. Sokol RJ, Booker DJ, Stamps R, et al. IgA red cell autoantibodies and autoimmune hemolysis. Transfusion 1997;37(2):175-81.[CrossRef][Medline]
  5. Clark DA, Dessypris EN, Jenkins DE Jr, et al. Acquired immune hemolytic anemia associated with IgA erythrocyte coating: investigation of hemolytic mechanisms. Blood 1984;64(5):1000-5.[Abstract/Free Full Text]
  6. Friedmann AM, King KE, Shirey RS, et al. Fatal autoimmune hemolytic anemia in a child due to warm-reactive immunoglobulin M antibody. J Pediatr Hematol Oncol 1998;20(5):502-5.[CrossRef][Medline]
  7. Sokol RJ, Booker DJ, Stamps R, et al. Autoimmune hemolytic anemia caused by warm-reacting IgM-class antibodies. Immunohematology 1998;14(2):53-8.




This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Khan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Khan, S.
Related Collections
Right arrow Screening tests
Right arrow Other immunology